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Abstract
The First International Conference on Toxicogenomics Integrated with Environmental Sciences
(TIES-2007) was held at the North Carolina State University McKimmon Center in Raleigh, North
Carolina on October 25th and 26th, 2007. Based on the presentations at the conference and the
commitment or interest of the presenters to contribute a manuscript of their research, we
compiled this collection of articles as proceedings of the conference and an in-depth topical review
of the utility of bioinformatics in the fields of toxicogenomics and environmental genomics.
Overview of the conference
The First International Conference on Toxicogenomics
Integrated with Environmental Sciences (TIES-2007) was
held at the North Carolina State University McKimmon
Center in Raleigh, North Carolina on October 25th and
26th, 2007 and had over 120 attendees from the United
States, China, Germany and Korea [1]. The TIES confer-
ences emphasize the application of bioinformatics in the
fields of toxicogenomics and environmental genomics
and provide a venue where diverse scientists can exchange
the current advances in bioinformatics for elucidating per-
turbed biological mechanisms and pathways through
'omics and advanced technologies. The theme of the TIES-
2007 conference was "bridging the toxicogenomics and
environmental genomics communities through bioinfor-
matics". The conference was organized by the National
Institutes of Health (NIH) – National Institute of Environ-
mental Health Science (NIEHS), the United States Food
and Drug Administration (FDA) – National Center for
Toxicological Research (NCTR) and the North Carolina
State University (NCSU) Bioinformatics Research Center
(BRC). Rosetta Biosoftware and JMP Genomics were
sponsors of the conference. TIES-2007 featured several
keynote speakers, a host of invited presentations and a
poster session covering topics related to toxicogenomics,
proteomics, bioinformatics, epigenetics, environmental
genomics and genetics, biomarker discovery, gene regula-
tory networks and systems biology. In addition, a special
session on the FDA-led MicroArray Quality Control
project [2,3] was provided that highlighted reproducibil-
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for cash awards for the oral presentation of their poster.
First place went to ClarLynda Williams of the Bioinfor-
matics Program at the NCSU BRC, second place to Yun-
jung Kim of the Bioinformatics Program at the NCSU
BRC, third place to Venus Welch at the Integrated Bio-
sciences Program at Tuskegee University and fourth place
to D. Ryan Georgianna at the Functional Genomics Pro-
gram at the NCSU BRC.
The advent of toxicogenomics, a combination of the fields
of toxicology and genomics, promises to facilitate the
identification of potential human and environmental tox-
icants, and their putative mechanism(s) of action,
through the use of genomics [4]. However, although a
wealth of data has been collected and analyzed to assess
risk and human health issues from exposure to toxicants,
very little is still known about the biological processes that
account for idiosyncratic toxicity or human genetics sus-
ceptibility to environmental stressors. Fortunately, envi-
ronmental health sciences and genomics have taken form
to leverage environmental exposures for a better under-
standing of the role of gene and gene-product expression
and genetic variation in the development and progression
of complex human diseases [5]. One of the main chal-
lenges in toxicogenomics and environmental genomics is
managing and making sense of the abundance of the data
to elucidate the interaction between genes and the envi-
ronment in the development and progression of human
diseases [6-10]. The papers presented in the TIES-2007
proceedings provide a glimpse of the utility of bioinfor-
matics in the fields of toxicogenomics and environmental
genomics, and a peak at the research advances and tech-
nologic developments at the forefront of these disciplines.
Below is a synopsis of the student oral presentations and
the MAQC special session that took place at TIES-2007.
Student oral presentations
ClarLynda Williams, a doctoral candidate in the bioinfor-
matics program at NCSU, Maritja Wolf from Lockheed
Martin and Ann Richards, her mentor at the Environmen-
tal Protection Agency (EPA), aimed to chemically index
the content of public genomic databases to make the data
accessible in relation to other publicly available, chemi-
cally-indexed toxicological information. The five public
genomic databases that contained data of chemogenomic
interest were the Chemical Effects in Biological Systems
(CEBS) knowledgebase, Public Expression Profiling
Resources (PEPR) web database, ArrayExpress genomic
repository, the Gene Expression Omnibus (GEO) reposi-
tory, and the Environment, Drugs, and Gene Expression
database (EDGE). After chemical exposure experiments
were identified, the chemical space was defined through
structural similarity and compared to the chemical space
of public toxicological data from the EPA DSSTox project
[11]. By evaluating the chemical space of public genomic
data in relation to public toxicological data, it was possi-
ble to identify classes of chemicals on which to develop
methodologies for the integration of chemogenomic data
into predictive toxicology by comparisons of experimen-
tal data across labs, chemicals, platforms and species.
Yunjung Kim, a doctoral candidate in the bioinformatics
program at NCSU and Zhao-Bang Zeng, her mentor at the
NCSU BRC, aimed to understand the multilocus linkage
disequlibrium (LD) structure among SNPs in the human
genome by testing hypotheses about 2- and 3-locus
gametic disequilibrium via a resampling method. The
usual way to test hypotheses about different orders of
gametic disequilibrium is the likelihood ratio test (LRT).
With large samples, the distribution of LRT statistic
approximates a chi-square distribution with the degree of
freedom equal to the difference of parameter numbers
between the null model and the alternative model. For
some tests such as two-locus gametic disequilibrium, the
chi-square approximation still works very well. However,
for tests of 3-locus or more gametic disequilibria, the
asymptotic chi-square approximation no longer works
especially when there are many unobserved haplotypes.
As an alternative choice, they used a resampling method
suggested by Long et al. [12] and constructed empirical
distributions of statistics by resampling the observed data.
Such empirical distributions avoid the large sample
assumption at the expense of more computing time and
may provide more reliable p-values for the test of higher
order LD. This resampling method is illustrated with sim-
ulation experiments and analysis of the phased haplotype
data from DeLuca et al. [13].
Venus Welch, a graduate student in integrative biosciences
with a focus in environmental toxicology and toxicoge-
nomics at Tuskegee University and Pierre R. Bushel, her
mentor at NIEHS, embarked on a summer internship
project in the Microarray and Genome Informatics group
at NIEHS to ascertain the differences in gene expression
patterns and biological pathways in the livers of rats
exposed to chemical agents. Microarray gene expression
data acquired from the livers of male Fisher rats, orally
dosed with 1, 2- or 1, 4-dichlorobenzene (DCB, isomers
used in pesticides) in single doses of 15, 150, and 1500
mg/kg for 6 and 24 hours was analyzed. A set of 463 genes
that are involved in toxic response pathways were used to
perform clustering and principal component analysis of
the data resulting in a separation of the exposed animals
by the toxic dose in 3-D space. Interestingly, at the 150
mg/kg for 24-hour exposure, ALT and AST enzyme levels
from the 1, 4-DCB-treated animals were equivalent to 1,
2-DCB-control animals, where no necrosis was observed.
However, the 1, 2-DCB-treated animals revealed elevated
levels of the enzymes as well as necrosis in comparison toPage 2 of 4
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measurements were effective in anchoring the gene
expression to the phenotype of the samples for pathways
analysis. A central regulating role of tumor necrosis factor
and genes that influence, or are related to, apoptosis, MAP
kinase signaling and metabolism in the liver were
revealed. However, carnitine palmitoyltransferase 2 was
found to be differentially expressed between the pathways
generated from the 1, 2- and the 1, 4-DCB 150 mg/kg for
24 hours treated animals. Recent evidence from the gene
expression analysis of a compendium of hepatotoxicants
(including this 1,2- and 1,4-DCB data) supports these
findings [14].
D. Ryan Georgianna, a doctoral candidate in the func-
tional genomics program at NCSU, his mentor Gary A.
Payne and others in the Department of Plant Pathology at
NCSU, utilized an adaptation of the stable isotope label-
ling by amino acids on cell culture (SILAC) procedure to
reliably quantify alterations in protein concentrations in
response to temperature changes that regulate the biosyn-
thesis of aflatoxin (a carcinogenic mycotoxin produced by
Aspergillus flavus – a fungus found on several commodities
such as corn, peanuts, cotton and tree nuts) [15]. SILAC
relies on the quantitative incorporation of labelled amino
acids into proteins to provide a powerful mass spectrom-
etry based proteomics tool for rapid quantification of pro-
teins. Aflatoxin production is inhibited at 37°C, the
optimum temperature for growth of A. flavus. The com-
parison between conducive (28°C) and nonconducive
(37°C) temperatures for aflatoxin biosynthesis revealed
31 proteins more abundant at 37°C and 18 more abun-
dant at 28°C. Interestingly, the particular changes in the
level of expression of the aflatoxin pathway enzymes
seemed to closely follow the strong repression of both
aflatoxin biosynthesis and transcription of the aflatoxin
pathway genes observed at 37°C. Transcripts were present
for 379 proteins quantified by SILAC, but their expression
did not always correlate well with transcript levels of
encoding genes. This is the first reported labelling of a
multicellular (whole organism) free-living prototroph
using the SILAC procedure to compare 13C6-arginine-
labeled samples to 12C6-arginine-labeled samples for
quantitative proteomics.
MicroArray Quality Control (MAQC) special session
The MAQC project is an FDA-led, community-wide effort
aimed at reaching consensus within the microarray
research community on best ways to assess quality, ana-
lyze and apply DNA microarrays. The MAQC project is
divided into two phases, the phase I effort (MAQC-I) is to
address the technical issues related to use of microarrays
while phase II (MAQC-II) is focused on the issues related
to the application of microarrays in clinics and risk assess-
ment. This special session is to communicate the MAQC-
I results and conclusions with the research community
through the TIES meeting.
Dr. Welda Tong from the FDA's National Center for Toxi-
cological Research, a principle investigator in MAQC,
started the session with an overview of the MAQC-I
project and the status of the MAQC-II program. Specifi-
cally, he emphasized the impact of this project to the reg-
ulatory use of the microarray-based data. He indicated
that the lessons learned from MAQC are paving the way
for development of a Best Practice Guidance Document
for future voluntary as well as regular submissions of
pharmacogenomics data to the FDA and he indicated that,
such a best practice document draft, a companion docu-
ment to "Guidance for Industry – Pharmacogenomic Data
Submission" was recently released for comments.
MAQC-I used six different commercial and one institu-
tionally developed microarray platforms. Over 130 scien-
tists from 51 organizations participated in the generation
and analysis of this dataset, and important conclusions
were drawn from this collaborative effort. Dr. Wendell
Jones from Expression Analysis summarized the main
findings and conclusions from MAQC-I. Specifically,
when standard operating procedures for an assay are fol-
lowed and the data is analyzed properly, the following is
demonstrated: (1) High repeatability (within site) and
reproducibility (between sites) for each platform; (2)
High cross-platform comparability, including one- vs.
two-color platforms; and (3) High correlation between
quantitative gene expression (e.g. TaqMan) and microar-
ray platforms, where the few discordant measurements
were found, mainly, due to probe sequence and thus tar-
get location. These findings were further discussed and
demonstrated in more detail by Dr. Yulin Luo's (Panom-
ics, Inc.) presentation on "Evaluation of DNA Microarray
Results with Quantitative Gene Expression Platforms",
Dr. Russ Wolfinger's (SAS) presentation on "Performance
Comparison of One-Color and Two-Color Platforms",
and Dr. Anne Lucas' (Agilent Technologies) presentation
on "Evaluation of External RNA Controls for the Assess-
ment of Microarray Performance".
The MAQC-I evaluated various gene selection rules to
determine the reproducible gene lists across labs and
across platforms. It was found that within-lab, cross-lab
and cross-platform reproducibility is likely to be reached
if fold change (FC) is used as a primary ranking/selection
criterion but not to be reached if p-value from a simple T-
test is used as a primary ranking/selection criterion. Dr. Ed
Lobenhofer (Cogenics, Inc.) discussed the results from the
rat toxicogenomic study of this project to demonstrate the
MAQC findings; i.e., FC ranking coupled with a less strin-
gent P-value cutoff might be a reasonable way to balance
reproducibility and statistical significance. These findingsPage 3 of 4
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could be one of the most important but also most contro-
versial conclusions from MAQC-I. Consequently, Dr. Russ
Wolfinger (SAS) presented a set of new studies based on a
simulated dataset to further illustrate the relationship
between the reproducibility and specificity/sensitivity in
microarray analysis. He demonstrated that there is no
monotonic relationship between reproducibility and spe-
cificity/sensitivity and then concluded that care should be
taken to align the selected analysis methods with the
study objectives. It appears that more extensive studies on
this subject are needed.
Future conferences
The next TIES conference will be held in Seoul, South
Korea in conjunction with a Symposium of the 5th Inter-
national Conference for Toxicogenomics, September 21-
23, 2009. TIES-2009 will be a joint conference with the
Korea Society on Toxicogenomics and Toxicoproteomics,
NIEHS, NCTR and the NCSU-BRC. The conference will be
held at the Renaissance Seoul Hotel. The conference web
sites will be http://www.ties-conference-2009.org and
http://www.tox.or.kr/toxsoc/event/ict-2009/.
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